10-Jul-2026
3M (MMM) and DuPont Hit by New York Lawsuit over ‘Forever Chemicals’ Pollution
TipRanks (Thu, 9-Jul 1:52 PM ET)
New York AG sues 3M, DuPont, others over PFAS ‘forever chemicals’
Seeking Alpha News (Thu, 9-Jul 12:43 PM ET)
Corteva and Arevo Partner on Soy Crop Nutrition
Globe Newswire (Fri, 3-Jul 10:00 AM ET)
Corteva Announces Board of Directors for Future Crop Protection Company
PRNewswire (Mon, 29-Jun 4:30 PM ET)
Corteva Announces Board of Directors for Advanced Seed and Genetics Spin-Off Vylor
PRNewswire (Mon, 29-Jun 4:30 PM ET)
FMC Corporation and Corteva Expand Access to Breakthrough Rimisoxafen Herbicide Technology
PRNewswire (Tue, 16-Jun 5:05 PM ET)
Corteva to Participate in Wolfe's Materials of the Future Conference
PRNewswire (Wed, 10-Jun 8:00 AM ET)
Corteva Announces Dates for Second Quarter 2026 Earnings Release and Webcast
PRNewswire (Thu, 21-May 8:00 AM ET)
Corteva Announces Headquarters for Two Future Companies Following Planned Separation
PRNewswire (Tue, 12-May 4:30 PM ET)
Corteva to Participate in BMO Global Farm to Market Conference
PRNewswire (Thu, 7-May 4:30 PM ET)
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva plans to spin off its seeds business in late 2026. The seeds business will be named Vylor, while the crop protection business will retain the Corteva name and be a pure-play crop protection company following the divestiture. Corteva operates globally, but around half of revenue comes from North America.
Corteva Common trades on the NYSE stock market under the symbol CTVA.
As of July 10, 2026, CTVA stock price climbed to $85.68 with 2,012,353 million shares trading.
CTVA has a beta of -0.10, meaning it tends to be less sensitive to market movements. CTVA has a correlation of 0.00 to the broad based SPY ETF.
CTVA has a market cap of $57.52 billion. This is considered a Large Cap stock.
Last quarter Corteva Common reported $5 billion in Revenue and $1.50 earnings per share. This beat revenue expectation by $265 million and exceeded earnings estimates by $.32.
In the last 3 years, CTVA traded as high as $87.69 and as low as $43.22.
The top ETF exchange traded funds that CTVA belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.
CTVA has underperformed the market in the last year with a return of +15.5%, while the SPY ETF gained +21.8%. In the last 3 month period, CTVA fell short of the market, returning +2.4%, while SPY returned +11.4%. However, in the most recent 2 weeks CTVA has outperformed the stock market by returning +3.7%, while SPY returned +3.6%.
CTVA support price is $82.50 and resistance is $85.22 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CTVA shares will trade within this expected range on the day.